Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study (Q83504542)
Jump to navigation
Jump to search
scientific article published on 01 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study |
scientific article published on 01 February 2012 |
Statements
Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study (English)
Lars Wallentin
Michael Ezekowitz
Stefan H Hohnloser
Paul Reilly
Greg Flaker
Martina Brueckmann